Veracyte (VCYT) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to 0.92.
- Veracyte's Equity Ratio fell 31.23% to 0.92 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.92, marking a year-over-year decrease of 31.23%. This contributed to the annual value of 0.9 for FY2024, which is 340.94% down from last year.
- Latest data reveals that Veracyte reported Equity Ratio of 0.92 as of Q3 2025, which was down 31.23% from 0.91 recorded in Q2 2025.
- Veracyte's Equity Ratio's 5-year high stood at 0.95 during Q1 2021, with a 5-year trough of 0.9 in Q4 2024.
- In the last 5 years, Veracyte's Equity Ratio had a median value of 0.93 in 2022 and averaged 0.93.
- In the last 5 years, Veracyte's Equity Ratio soared by 1016.16% in 2021 and then crashed by 340.94% in 2024.
- Over the past 5 years, Veracyte's Equity Ratio (Quarter) stood at 0.92 in 2021, then increased by 0.72% to 0.93 in 2022, then rose by 0.72% to 0.94 in 2023, then decreased by 3.41% to 0.9 in 2024, then increased by 1.65% to 0.92 in 2025.
- Its Equity Ratio was 0.92 in Q3 2025, compared to 0.91 in Q2 2025 and 0.91 in Q1 2025.